Chain of Infection

Overview

The chain of infection is a six-link epidemiological model that describes the conditions necessary for an infectious disease to spread from one host to another. Understanding each link in this chain allows nurses and other healthcare professionals to implement targeted, evidence-based interventions that interrupt transmission, protect patients and staff, and reduce the burden of healthcare-associated infections (HAIs). Approximately one in every 31 hospitalized patients in the United States has at least one HAI on any given day (CDC, 2022), making infection control a patient safety priority of the highest order.

Each link in the chain must remain intact for transmission to occur. The strategic power of this model lies in its corollary: breaking any single link will prevent infection. Nurses are positioned at every point of potential interruption — from aseptic technique and hand hygiene to patient education and environmental decontamination.

---

The Six Links of the Chain of Infection

Link 1: Infectious Agent

The infectious agent (also called the pathogen) is the microorganism capable of causing disease. Pathogens are classified by type, and understanding their characteristics informs the selection of appropriate precautions, disinfectants, and antimicrobial treatments.

Agent Class	Examples	Key Characteristics
Bacteria	Staphylococcus aureus (MRSA), Mycobacterium tuberculosis, Clostridium difficile, Escherichia coli	Single-celled prokaryotes; may form spores (e.g., C. diff); treated with antibiotics (susceptibility varies)
Viruses	Influenza A/B, SARS-CoV-2, HIV, Norovirus, Hepatitis B/C	Require host cell machinery to replicate; not killed by antibiotics; managed with antivirals or supportive care
Fungi	Candida albicans, Aspergillus fumigatus, Histoplasma capsulatum	Eukaryotic; opportunistic infections common in immunocompromised patients; treated with antifungals
Parasites	Plasmodium spp. (malaria), Toxoplasma gondii, Giardia lamblia	Eukaryotic; lifecycle often spans multiple hosts; treated with antiparasitic agents
Prions	Creutzfeldt-Jakob disease (CJD) agent	Misfolded proteins; extraordinarily resistant to standard sterilization; no effective treatment

The virulence (ability to cause disease), infectivity (ability to establish infection), pathogenicity (ability to produce pathological changes), and toxigenicity (ability to produce toxins) of a pathogen all influence the severity of disease and the urgency of containment measures.

Link 2: Reservoir

The reservoir is the habitat in which the infectious agent normally lives, grows, and reproduces. Reservoirs serve as the ongoing source from which pathogens can be acquired.

• Human reservoirs — Infected individuals (symptomatic or asymptomatic carriers) are the most common reservoir for communicable diseases. MRSA colonization without active infection is a clinically significant example; approximately 30% of the population carry Staphylococcus aureus asymptomatically in the nares.
• Animal reservoirs (zoonoses) — Some pathogens cycle between animal hosts and humans. Salmonella spp. are shed in poultry and reptiles; rabies circulates in wildlife populations; influenza A strains evolve in avian and swine reservoirs before acquiring human-transmissible mutations.
• Environmental reservoirs — Aspergillus spores are ubiquitous in soil and decaying organic matter. Legionella pneumophila colonizes water systems including hospital cooling towers and plumbing. Histoplasma capsulatum is associated with soil containing bird or bat droppings.

Nursing implications at the reservoir link include patient cohorting, prompt culture and sensitivity testing, aseptic wound care, and environmental cleaning protocols that target known reservoirs (e.g., hospital water management plans for Legionella).

Link 3: Portal of Exit

The portal of exit is the route by which the pathogen leaves the reservoir and becomes capable of transmission. Common portals of exit from a human reservoir include:

• Respiratory tract — coughing, sneezing, talking, or suctioning releases droplets and aerosols containing Mycobacterium tuberculosis, influenza virus, SARS-CoV-2, and Bordetella pertussis.
• Gastrointestinal tract — fecal material and vomitus carry C. difficile spores, Norovirus, Salmonella, and E. coli O157:H7. Fecal-oral transmission is facilitated when hand hygiene or food handling practices are inadequate.
• Genitourinary tract — HIV, Hepatitis B, Neisseria gonorrhoeae, and Chlamydia trachomatis exit via urogenital secretions and urine.
• Blood and body fluids — bloodborne pathogens (HIV, Hepatitis B, Hepatitis C) exit through sharps injuries, mucous membrane exposures, and unsafe injection practices.
• Skin/wound — Staphylococcus aureus and streptococcal species exit from wound drainage, exudate, and desquamating (shedding) skin.

Nursing interventions that address portals of exit include respiratory hygiene and cough etiquette, proper disposal of bodily waste, Standard Precautions with all patients, and vigilance during procedures that generate aerosols or expose staff to blood.

Link 4: Mode of Transmission

The mode of transmission describes how the pathogen travels from the portal of exit to a new host. The CDC and HICPAC recognize the following major transmission modes, each of which drives a corresponding category of Transmission-Based Precautions:

Transmission Mode	Mechanism	Examples	Precaution Category
Contact — Direct	Physical skin-to-skin or mucous membrane contact	MRSA, VRE, scabies	Contact Precautions
Contact — Indirect	Contaminated intermediate object (fomite)	C. difficile (via environmental surfaces), RSV (via toys/surfaces)	Contact Precautions
Droplet	Large respiratory droplets (>5 µm) that travel ≤3–6 feet	Influenza, Neisseria meningitidis, pertussis	Droplet Precautions
Airborne	Small droplet nuclei (≤5 µm) that remain suspended and travel >6 feet	Mycobacterium tuberculosis, measles (rubeola), varicella	Airborne Precautions + AIIR
Vector-borne	Biologic vector (e.g., mosquito, tick)	Malaria (Plasmodium), Lyme disease (Borrelia burgdorferi), West Nile virus	Environmental control, repellents
Vehicle	Contaminated food, water, blood products, or IV solutions	Salmonella (food), Legionella (water), Hepatitis C (blood)	Source elimination, safe injection practices

Link 5: Portal of Entry

The portal of entry is the site through which the pathogen gains access to the new host. Many portals of entry mirror portals of exit, reflecting organism-specific tropism:

• Respiratory mucosa — M. tuberculosis bacilli are inhaled and deposited in alveoli; influenza virus and SARS-CoV-2 bind to ACE2 receptors in the upper and lower airways.
• Gastrointestinal mucosa — C. difficile spores are ingested and germinate in the colon; Norovirus enters via oral ingestion of contaminated food or water.
• Non-intact skin — Breaks in skin integrity (wounds, burns, IV insertion sites, pressure injuries) create portals for S. aureus, gram-negative bacilli, and fungal organisms.
• Mucous membranes (eyes, genitals) — Bloodborne and sexually transmitted pathogens (HIV, Hepatitis B, gonorrhea, herpes simplex virus) enter through conjunctival and genitourinary mucosa.
• Parenteral route — Needlestick injuries, sharps exposures, and IV drug use create direct portals into the bloodstream for HIV, Hepatitis B, and Hepatitis C.
• Placental/transplacental route — Congenital transmission of Toxoplasma, rubella, CMV, HSV, and HIV can occur via the placenta or during delivery.

Nursing strategies targeting portals of entry include meticulous aseptic technique during invasive procedures, appropriate use of personal protective equipment (PPE), pressure injury prevention, and patient education regarding safe sexual practices and injection equipment.

Link 6: Susceptible Host

The susceptible host is the final link — the individual who is vulnerable to infection because they lack sufficient immunity or physical defenses to resist the pathogen. Host susceptibility is determined by a complex interplay of factors:

• Immune status — Immunocompromised patients (e.g., those receiving chemotherapy, corticosteroids, or post-transplant immunosuppression; patients with HIV/AIDS; neonates; older adults) mount inadequate adaptive immune responses.
• Age — Infants lack mature immune systems; older adults experience immunosenescence and declining mucociliary function, increasing susceptibility to influenza, pneumonia, and urinary tract infections.
• Chronic disease — Diabetes mellitus impairs neutrophil function and wound healing; chronic obstructive pulmonary disease compromises mucociliary clearance; chronic kidney disease reduces immune surveillance.
• Nutritional status — Malnutrition and micronutrient deficiencies (zinc, vitamin C, vitamin D) impair wound healing, cellular immunity, and mucosal barrier integrity.
• Vaccination status — Unvaccinated individuals are fully susceptible to vaccine-preventable diseases (influenza, COVID-19, hepatitis B, pertussis, varicella, measles).
• Skin and mucous membrane integrity — Intact barriers are the first line of physical defense. Invasive devices, wounds, and skin conditions that disrupt integrity markedly increase susceptibility.
• Indwelling devices — Urinary catheters, central venous catheters, and endotracheal tubes create direct conduits that bypass normal host defenses.

Nursing actions that address host susceptibility include comprehensive patient risk assessment, administering prescribed vaccinations, optimizing nutrition, minimizing invasive device use, daily assessment of device necessity, and patient and family education.

---

Common Infectious Agents and Their Place in the Chain

The following section maps five clinically significant pathogens to each link in the chain of infection, illustrating how the model applies in practice.

Methicillin-Resistant Staphylococcus aureus (MRSA)

MRSA is a gram-positive bacterium resistant to beta-lactam antibiotics that is a leading cause of both community-acquired and healthcare-associated infections, including skin and soft tissue infections, pneumonia, and bacteremia.

Chain Link	MRSA-Specific Details
Infectious Agent	S. aureus resistant to methicillin/oxacillin; may produce Panton-Valentine leukocidin (PVL) toxin in community strains
Reservoir	Human nares (asymptomatic colonization), skin, wounds, healthcare environment (surfaces, equipment)
Portal of Exit	Wound drainage, respiratory secretions, skin desquamation
Transmission Mode	Direct and indirect contact (fomites — stethoscopes, blood pressure cuffs, bed rails)
Portal of Entry	Non-intact skin (wounds, IV sites, surgical incisions), respiratory mucosa
Susceptible Host	Post-surgical patients, ICU patients with invasive devices, immunocompromised individuals, older adults, patients with chronic skin conditions
Nursing Interventions	Contact Precautions; dedicated or single-use equipment; daily chlorhexidine bathing in ICU patients; active surveillance cultures per facility protocol

Mycobacterium tuberculosis (TB)

TB remains a global public health emergency. Latent TB infection (LTBI) may reactivate in immunocompromised individuals. Active pulmonary TB is one of the few diseases that requires Airborne Precautions in healthcare settings.

Chain Link	TB-Specific Details
Infectious Agent	Aerobic, acid-fast bacillus; slow-growing; forms granulomas in lung tissue; resistance patterns (MDR-TB, XDR-TB) are increasing concerns
Reservoir	Humans with active pulmonary or laryngeal TB; cattle (M. bovis) in some geographic regions
Portal of Exit	Respiratory tract — coughing, sneezing, singing, speaking, or procedures such as bronchoscopy
Transmission Mode	Airborne — infectious droplet nuclei ≤5 µm remain suspended in air for hours
Portal of Entry	Lower respiratory tract (alveoli)
Susceptible Host	HIV-positive individuals, malnourished persons, those on immunosuppressive therapy, unvaccinated individuals (BCG not routinely given in the US), incarcerated populations, those with prior untreated LTBI
Nursing Interventions	Airborne Precautions; Airborne Infection Isolation Room (AIIR) with negative pressure; N95 respirator (fit-tested); prompt sputum testing; mandatory reporting to public health; contact investigation

Influenza Virus (Seasonal Influenza A/B)

Influenza causes significant seasonal morbidity and mortality, particularly among high-risk populations. Annual vaccination is the most effective preventive strategy.

Chain Link	Influenza-Specific Details
Infectious Agent	Single-stranded RNA orthomyxovirus; antigenic drift (minor mutations) and antigenic shift (major reassortment) drive seasonal strain variation and pandemic potential
Reservoir	Humans (seasonal strains); avian and swine reservoirs for novel pandemic strains
Portal of Exit	Respiratory tract — coughing, sneezing; infectious 1 day before and up to 5–7 days after symptom onset
Transmission Mode	Droplet (primary); contact with contaminated surfaces; limited airborne component in closed spaces
Portal of Entry	Upper respiratory mucosa (nasopharynx); conjunctiva
Susceptible Host	Unvaccinated individuals; adults ≥65 years; children <5 years; pregnant persons; those with chronic cardiopulmonary disease, diabetes, or immunosuppression
Nursing Interventions	Droplet Precautions; annual vaccination for all staff and patients; antiviral therapy (oseltamivir) within 48 hours of symptom onset for high-risk patients; respiratory hygiene and cough etiquette

Clostridioides difficile (C. diff)

C. difficile colitis is the most common cause of healthcare-associated diarrhea in the United States. Its ability to form robust spores that resist alcohol-based disinfectants makes environmental decontamination a central prevention strategy.

Chain Link	C. difficile-Specific Details
Infectious Agent	Anaerobic, spore-forming, gram-positive bacillus; toxin A (enterotoxin) and toxin B (cytotoxin) damage colonic mucosa; hypervirulent ribotype 027 (NAP1) produces increased toxin levels
Reservoir	Colonized or infected humans; healthcare environment (surfaces, commodes, call lights, bed rails); soil
Portal of Exit	Gastrointestinal tract — feces, vomitus
Transmission Mode	Contact (fecal-oral) — indirect contact via fomites is the dominant route in healthcare settings; spores persist on surfaces for months
Portal of Entry	Gastrointestinal tract (oral ingestion of spores)
Susceptible Host	Patients on broad-spectrum antibiotics (which disrupt normal flora), proton pump inhibitors, older adults, immunocompromised patients, those with prior C. difficile infection
Nursing Interventions	Contact Precautions; soap-and-water handwashing (not alcohol); sporicidal disinfectant (sodium hypochlorite/bleach) for environmental surfaces; single-patient-use or dedicated equipment; judicious antibiotic stewardship

SARS-CoV-2 (COVID-19)

COVID-19 demonstrated how rapidly a novel pathogen with multi-modal transmission and a large proportion of asymptomatic carriers can exploit the chain of infection at a global scale.

Chain Link	SARS-CoV-2-Specific Details
Infectious Agent	Beta-coronavirus; positive-sense single-stranded RNA; spike protein binds ACE2 receptor; ongoing antigenic evolution (variants of concern)
Reservoir	Humans (primary); probable animal origin (bats, possible intermediate hosts); animal-to-human spillover events under investigation
Portal of Exit	Respiratory tract — exhaled aerosols and droplets; pre-symptomatic and asymptomatic individuals are major drivers of transmission
Transmission Mode	Airborne/droplet continuum — short-range aerosol and droplet transmission predominates; long-range airborne transmission in poorly ventilated enclosed spaces; contact transmission via fomites (lower contribution)
Portal of Entry	Respiratory mucosa (nasopharynx, lower airways); conjunctiva; ACE2 receptor binding in multiple organ systems
Susceptible Host	Unvaccinated individuals; older adults; those with obesity, diabetes, cardiovascular disease, immunosuppression, or chronic lung disease; pregnancy increases severity risk
Nursing Interventions	At minimum Droplet + Contact Precautions; N95 respirator recommended for aerosol-generating procedures; AIIR for AGPs; vaccination of staff and patients; enhanced room ventilation; monitoring for variants and updated vaccine formulations

---

Nursing Interventions Across the Chain

Effective infection prevention requires systematic action at every link. The table below provides a summary framework that nurses can apply in daily clinical practice.

Chain Link	Standard Precautions	Transmission-Based Additions	Patient/Environmental Actions
Infectious Agent	Culture and sensitivity testing; antibiotic stewardship	Pathogen-specific treatment protocols	Educate patient on completing prescribed antimicrobial courses
Reservoir	Treat colonized/infected patients promptly	Cohorting; surveillance cultures	Environmental cleaning; water system management
Portal of Exit	Proper disposal of sharps, body fluids, and waste	Respiratory hygiene; cough etiquette coaching	Provide masks and tissues; instruct patients to cover coughs
Transmission Mode	Hand hygiene before and after all patient contact; gloves, gown, mask as indicated	Contact, Droplet, or Airborne Precautions per pathogen; AIIR for airborne pathogens	Clean and disinfect shared equipment; dedicated or single-use items
Portal of Entry	Aseptic technique for invasive procedures; intact PPE; sharps safety	Additional respiratory protection (N95) for airborne; eye protection per splash risk	Wound care; pressure injury prevention; minimize invasive device days
Susceptible Host	Daily device-necessity assessment; optimize nutrition; skin care	Immunocompromised patients: protective environment (positive-pressure room)	Vaccination; hand hygiene education; patient empowerment

---

Key Takeaways for BSN Practice

Infection prevention is not a passive activity — it requires active, deliberate decision-making grounded in an understanding of how pathogens move through the environment and exploit host vulnerability. The chain of infection model provides the conceptual scaffold for that decision-making. BSN-prepared nurses should be able to:

1. Rapidly identify the probable transmission mode of any pathogen they encounter and initiate the corresponding precaution category before culture results are confirmed.
2. Implement and maintain Standard Precautions with every patient, regardless of known diagnosis, recognizing that reservoirs are often invisible.
3. Prioritize hand hygiene — the single most effective intervention — and model excellent technique for colleagues, students, and patients.
4. Collaborate with the interprofessional team (infection preventionists, pharmacists, physicians, environmental services) to implement bundle-based prevention strategies for device-associated HAIs (CLABSI, CAUTI, VAP).
5. Advocate for appropriate antibiotic stewardship to preserve the efficacy of antimicrobials and reduce the selection pressure that drives resistance.

---

References

• Centers for Disease Control and Prevention. (2022). Healthcare-associated infections (HAIs). https://www.cdc.gov/hai/
• Centers for Disease Control and Prevention. (2023). Guideline for isolation precautions: Preventing transmission of infectious agents in healthcare settings. https://www.cdc.gov/infectioncontrol/guidelines/isolation/
• Heymann, D. L. (Ed.). (2022). Control of communicable diseases manual (21st ed.). American Public Health Association.
• Siegel, J. D., Rhinehart, E., Jackson, M., Chiarello, L., & the Healthcare Infection Control Practices Advisory Committee. (2007, updated 2019). 2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. CDC/HICPAC.
• World Health Organization. (2021). WHO guidelines on hand hygiene in health care. https://www.who.int/publications/i/item/9789241597906